Business Focus
Clinical Focus
Spotlight
Academy
CME/CE
Job Board
Subscribe
- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
The role of primary care physicians in cognitive screening for early stage Alzheimer's
What is the role for primary care physicians in screening for cognitive issues such as Alzheimer’s and dementia? And what challenges do practices have in getting their patients these screenings?
New early stage Alzheimer’s disease treatments — such as Lecanemabwhich was recently given accelerated approval from the FDA — are preparing to be launched into the market place. As a result, patients will want to learn more about the importance of cognitive screening and their treatment options.
Medical Economics sat down with John Showalter, M.D., of Linus Health, to discuss the role for primary care physicians in screening for cognitive issues such as Alzheimer’s and dementia.
